ReP USP - Resultado da busca

Artigo de periodico
Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry (2019)
Filgueira, Fernando Paranaiba; Lobato, Núbia de Souza; Nascimento, Denise L.; Ceravolo, Graziela Scalianti; Giachini, Fernanda R. C.; Lima, Victor V.; Dantas, Ana Paula; Fortes, Zuleica Bruno; Webb, R. Clinton; Tostes, Rita de Cássia Aleixo ; Carvalho, Maria Helena Catelli de
Source: Steroids. Unidades: ICB, FMRP
Subjects: ESTRADIOL, ARTÉRIAS, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Fernando Paranaiba et al. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, v. 141, p. 46-54, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.steroids.2018.11.006. Acesso em: 14 nov. 2024.
APA
Filgueira, F. P., Lobato, N. de S., Nascimento, D. L., Ceravolo, G. S., Giachini, F. R. C., Lima, V. V., et al. (2019). Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, 141, 46-54. doi:10.1016/j.steroids.2018.11.006
NLM
Filgueira FP, Lobato N de S, Nascimento DL, Ceravolo GS, Giachini FRC, Lima VV, Dantas AP, Fortes ZB, Webb RC, Tostes R de CA, Carvalho MHC de. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry [Internet]. Steroids. 2019 ; 141 46-54.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.steroids.2018.11.006
Vancouver
Filgueira FP, Lobato N de S, Nascimento DL, Ceravolo GS, Giachini FRC, Lima VV, Dantas AP, Fortes ZB, Webb RC, Tostes R de CA, Carvalho MHC de. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry [Internet]. Steroids. 2019 ; 141 46-54.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.steroids.2018.11.006
Artigo de periodico
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia (2018)
Gomes, Felipe Villela ; Edelson, Jessica R.; Volk, David W.; Grace, Anthony A.
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, CÉREBRO, CRESCIMENTO E DESENVOLVIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela et al. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, v. 201, p. 254-260, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2018.04.030. Acesso em: 14 nov. 2024.
APA
Gomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018). Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, 201, 254-260. doi:10.1016/j.schres.2018.04.030
NLM
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Vancouver
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Artigo de periodico
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 (2018)
Lisboa, Sabrina Francesca; Niraula, Anzela; Resstel, Leonardo Barbosa Moraes; Guimarães, Francisco Silveira; Godbout, Jonathan P.; Sheridan, John F.
Source: Neuropsychopharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ANSIEDADE, MEDO, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, Sabrina Francesca et al. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. Neuropsychopharmacology, v. 43, n. 9, p. 1924-1933, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41386-018-0064-2. Acesso em: 14 nov. 2024.
APA
Lisboa, S. F., Niraula, A., Resstel, L. B. M., Guimarães, F. S., Godbout, J. P., & Sheridan, J. F. (2018). Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. Neuropsychopharmacology, 43( 9), 1924-1933. doi:10.1038/s41386-018-0064-2
NLM
Lisboa SF, Niraula A, Resstel LBM, Guimarães FS, Godbout JP, Sheridan JF. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 [Internet]. Neuropsychopharmacology. 2018 ; 43( 9): 1924-1933.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41386-018-0064-2
Vancouver
Lisboa SF, Niraula A, Resstel LBM, Guimarães FS, Godbout JP, Sheridan JF. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 [Internet]. Neuropsychopharmacology. 2018 ; 43( 9): 1924-1933.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41386-018-0064-2
Artigo de periodico
SOCS1 is a negative regulator of metabolic reprogramming during sepsis (2017)
Piñeros Alvarez, Annie Rocio; Glosson-Byers, Nicole; Brandt, Stephanie; Wang, Soujuan; Wong, Hector; Sturgeon, Sarah; McCarthy, Brian Paul; Territo, Paul R.; Alves Filho, José Carlos Farias; Serezani, Carlos Henrique
Source: JCI Insight. Unidade: FMRP
Assunto: SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIÑEROS ALVAREZ, Annie Rocio et al. SOCS1 is a negative regulator of metabolic reprogramming during sepsis. JCI Insight, v. 2, n. 13, 2017Tradução . . Disponível em: https://doi.org/10.1172/jci.insight.92530. Acesso em: 14 nov. 2024.
APA
Piñeros Alvarez, A. R., Glosson-Byers, N., Brandt, S., Wang, S., Wong, H., Sturgeon, S., et al. (2017). SOCS1 is a negative regulator of metabolic reprogramming during sepsis. JCI Insight, 2( 13). doi:10.1172/jci.insight.92530
NLM
Piñeros Alvarez AR, Glosson-Byers N, Brandt S, Wang S, Wong H, Sturgeon S, McCarthy BP, Territo PR, Alves Filho JCF, Serezani CH. SOCS1 is a negative regulator of metabolic reprogramming during sepsis [Internet]. JCI Insight. 2017 ; 2( 13):[citado 2024 nov. 14 ] Available from: https://doi.org/10.1172/jci.insight.92530
Vancouver
Piñeros Alvarez AR, Glosson-Byers N, Brandt S, Wang S, Wong H, Sturgeon S, McCarthy BP, Territo PR, Alves Filho JCF, Serezani CH. SOCS1 is a negative regulator of metabolic reprogramming during sepsis [Internet]. JCI Insight. 2017 ; 2( 13):[citado 2024 nov. 14 ] Available from: https://doi.org/10.1172/jci.insight.92530
Artigo de periodico
A novel peptide that improves metabolic parameters without adverse central nervous system effects (2017)
Reckziegel, Patricia ; Festuccia, William Tadeu Lara ; Britto, Luiz Roberto Giorgetti de ; Heimann, Joel Cláudio ; Guimarães, Francisco Silveira ; Eichler, Rosangela Aparecida dos Santos ; Ferro, Emer Suavinho
Source: Scientific reports. Unidades: ICB, FM, FMRP
Subjects: PEPTÍDEOS, METABOLISMO, SISTEMA NERVOSO CENTRAL, FARMACOLOGIA, FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RECKZIEGEL, Patricia et al. A novel peptide that improves metabolic parameters without adverse central nervous system effects. Scientific reports, v. 7, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-13690-9. Acesso em: 14 nov. 2024.
APA
Reckziegel, P., Festuccia, W. T. L., Britto, L. R. G. de, Heimann, J. C., Guimarães, F. S., Eichler, R. A. dos S., & Ferro, E. S. (2017). A novel peptide that improves metabolic parameters without adverse central nervous system effects. Scientific reports, 7. doi:10.1038/s41598-017-13690-9
NLM
Reckziegel P, Festuccia WTL, Britto LRG de, Heimann JC, Guimarães FS, Eichler RA dos S, Ferro ES. A novel peptide that improves metabolic parameters without adverse central nervous system effects [Internet]. Scientific reports. 2017 ; 7[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41598-017-13690-9
Vancouver
Reckziegel P, Festuccia WTL, Britto LRG de, Heimann JC, Guimarães FS, Eichler RA dos S, Ferro ES. A novel peptide that improves metabolic parameters without adverse central nervous system effects [Internet]. Scientific reports. 2017 ; 7[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41598-017-13690-9

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation